Generalizability of the FOURIER Trial to Routine Clinical Care: Do Trial Participants Represent Patients in Everyday Practice?

ConclusionsOne in seven ASCVD patients in practice would have qualified for FOURIER. The excluded and under-represented populations were at a particularly low or high cardiovascular risk. Statin therapy was under-used and physicians may need to evaluate adherence before adding PCSK9i.
Source: American Heart Journal - Category: Cardiology Source Type: research